A new means for allowing a summary accurate prostate cancer test than the conventional and non-invasively has been disclosed. The present inventors have made intensive analyzed urine specimens of non-cancer subjects not suffering from prostate cancer patients and prostate cancer, newly found the ...
Those with prostate cancer showed high HAAH levels, whereas none of the normal control individuals did, the researchers reported at the American Association for Cancer Research’s Molecular Diagnostics in Cancer Therapeutic Development meeting in Chicago. “We hope our HAAH blood test, combined with P...
the team of biologists, clinical oncologists, pathologists and information scientists fromETH Zurich,University Hospital Zurichand theCantonal Hospital of St. Gallenhave determined a biomarker for prostate cancer – a particular pattern of proteins in the ...
HRRm are estimated to be present in up to 28% of patients (pts) with advanced prostate cancer, including metastatic castration-resistant prostate cancer (mCRPC). Testing for HRRm may inform treatment choice in pts with mCRPC. The aim of the study was to assess HRRm testing rate and describe...
Prostate cancer diagnosis using the PSA test remains controversial because of overdiagnosis and overtreatment of potentially indolent cancers. There remains a need to increase the diagnostic lead time and to target treatment to patients with significant
INTRODUCTION AND OBJECTIVES ERG (avian v-ets erythroblastosis virus E26 oncogene homolog) gene rearrangement and over-expression with potential functional consequences has been detected in 40-50% of men with prostate cancer. The utilization of ERG as an additional biomarker to prostate specific antigen...
Urinary prostate cancer 3 test: toward the age of reason? The prostate cancer 3 (PCA3) gene was discovered in 1999, on the basis of differential expression between cancer and noncancerous prostate tissue. Includin... V Vlaeminck-Guillem,A Ruffion,J André,... - 《Urology》 被引量: 183发...
be caused by benign prostate conditions. As a result, an elevated PSA test can sometimes lead to an unnecessary prostate biopsy for the patient, which carries a risk of bleeding and infection. Findings from this research may offer a more accurate and reliable method to diagnose prostate cancer....
This study was possible because of Mayo’s unique patient registry for prostate cancer. The registry contains hundreds of discrete pieces of information, ranging from environmental factors to specific medical test results, for more than 15,000 prostate cancer patients, all followed prospectively since ...
Multiparametric magnetic resonance imaging (mpMRI) has improved the early detection of clinically significant prostate cancer (csPCa). However, an appropriate selection of men for mpMRI or prostate biopsy is still challenging, which is why new biomarkers or predictive models are recommended to determin...